JMP Securities downgraded Notable Labs to Market Perform from Outperform without a price target. The company is restructuring its business and the future of lead asset volasertib is unclear, the analyst tells investors in a research note. The firm now sees the shares as fairly valued.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTBL: